Carregant...
Antiviral activity of maribavir in combination with other drugs active against human cytomegalovirus
The human cytomegalovirus (CMV) UL97 kinase inhibitor maribavir is in Phase III clinical trials as antiviral therapy, including use for infections refractory or resistant to standard therapy. To assess its activity in combination with approved and experimental CMV antivirals, and with the mTor inhib...
Guardat en:
| Publicat a: | Antiviral Res |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6097806/ https://ncbi.nlm.nih.gov/pubmed/30040968 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2018.07.013 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|